Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources

Journal of Clinical Microbiology

Volumn 43, Issue 6, 2005, Pages 2771-2781

  Parker, Craig T ^a   Horn, Sharon T ^a   Gilbert, Michel ^b   Miller, William G ^a   Woodward, David L ^c   Mandrell, Robert E ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOSYNTHESIS; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SYNTHESIS; GENE AMPLIFICATION; GENE LOCUS; GENETIC ORGANIZATION; GUILLAIN BARRE SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPE;

ANIMALS; BACTERIAL PROTEINS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; ENVIRONMENTAL MICROBIOLOGY; GUILLAIN-BARRE SYNDROME; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; SEQUENCE ANALYSIS, DNA; SEROTYPING;

CAMPYLOBACTER JEJUNI;

EID: 20444497695     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.6.2771-2781.2005     Document Type: Article

References (30)

1. Allos, B. M. 1997. Association between Campylobacter infection and Guillain-Barre syndrome. J. Infect. Dis. 176(Suppl. 2):S125-S128.
2. Dorrell, N., J. A. Mangan, K. G. Laing, J. Hinds, D. Linton, H. Al-Ghusein, B. G. Barrell, J. Parkhill, N. G. Stoker, A. V. Karlyshev, P. D. Butcher, and B. W. Wren. 2001. Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity. Genome Res. 11:1706-1715.
3. Fry, B. N., V. Korolik, B. A. van der Zeijst, and P. J. Coloe. 1998. A gene cluster from Campylobacter jejuni involved in inner core and lipid A synthesis. NCBI accession number AJ131360. Applied Biology and Biotechnology, Royal Melbourne Institute of Technology University, Melbourne, Australia.
4. Gilbert, M., J. Bellefeuille, M. F. Karwaski, A. M. Cunningham, and W. W. Wakarchuk. 2001. Partial sequence of the lipooligosaccharide biosynthesis locus of Campylobacter jejuni O:3. NCBI accession number AF411225. Institute for Biological Sciences. National Research Council of Canada, Montreal, Canada.
5. 13C NMR analysis. J. Biol. Chem. 275:3896-3906.
6. Gilbert, M., P. C. Godschalk, M. F. Karwaski, C. W. Ang, A. van Belkum, J. Li, W. W. Wakarchuk, and H. P. Endtz. 2004. Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barre syndrome, by horizontal exchange. Infect. Immun. 72:1162-1165.
7. Gilbert, M., M. F. Karwaski, S. Bernatchez, N. M. Young, E. Taboada, J. Michniewicz, A. M. Cunningham, and W. W. Wakarchuk. 2002. The genetic basis for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J. Biol. Chem. 277:327-337.
8. Gilbert, M., R. K. Singh, M.-F. Karwaski, and W. W. Wakarchuk. 2002. Sequencing of the lipo-oligosaccharide biosynthesis locus of Campylobacter jejuni LIO87. NCBI accession number AF40069. Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada.
9. Godschalk, P. C., A. P. Heikema, M. Gilbert, T. Komagamine, C. W. Ang, J. Glerum, D. Brochu, J. Li, N. Yuki, B. C. Jacobs, A. van Belkum, and H. P. Endtz. 2004. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J. Clin. Investig. 114:1659-1665.
10. Guerry, P., C. P. Ewing, T. E. Hickey, M. M. Prendergast, and A. P. Moran. 2000. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect. Immun. 68:6656-6662.
11. Guerry, P., C. M. Szymanski, M. M. Prendergast, T. E. Hickey, C. P. Ewing, D. L. Pattarini, and A. P. Moran. 2002. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect. Immun. 70:787-793.
12. Karlyshev, A. V., D. Linton, N. A. Gregson, A. J. Lastovica, and B. W. Wren. 2000. Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol. Microbiol. 35:529-541.
13. Lastovica, A. J., E. A. Goddard, and A. C. Argent. 1997. Guillain-Barre syndrome in South Africa associated with Campylobacter jejuni O:41 strains. J. Infect. Dis. 176(Suppl. 2):S139-S143.
14. Leonard, E. E., II, T. Takata, M. J. Blaser, S. Falkow, L. S. Tompkins, and E. C. Gaynor. 2003. Use of an open-reading frame-specific Campylobacter jejuni DNA microarray as a new genotyping tool for studying epidemiologically related isolates. J. Infect. Dis. 187:691-694.
15. Leonard, E. E., II, L. S. Tompkins, S. Falkow, and I. Nachamkin. 2004 Comparison of Campylobacter jejuni isolates implicated in Guillain-Barre syndrome and strains that cause enteritis by a DNA microarray. Infect. Immun. 72:1199-1203.
16. 1-like lipo-oligosaccharide of Campylobacter jejuni. Mol. Microbiol. 37:501-514.
17. Linton, D., A. V. Karlyshev, P. G. Hitchen, H. R. Morris, A. Dell, N. A. Gregson, and B. W. Wren. 2000. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide. Mol. Microbiol. 35:1120-1134.
18. McCarthy, N., Y. Andersson, V. Jormanainen, O. Gustavsson, and J. Giesecke. 1999. The risk of Guillain-Barre syndrome following infection with Campylobacter jejuni. Epidemiol. Infect. 122:15-17.
19. Miller, W. G., A. H. Bates, S. T. Horn, M. T. Brandl, M. R. Wachtel, and R. E. Mandrell. 2000. Detection on surfaces and in Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yjp, and cfp marker plasmids. Appl. Environ. Microbiol. 66:5426-5436.
20. Moran, A. P. 1997. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. J. Infect. Dis. 176(Suppl. 2):S115-S121.
21. 1a-like epitope. Infect. Immun. 70:5299-5303.
22. Oldfleld, N. J., A. P. Moran, L. A. Millar, M. M. Prendergast, and J. M. Ketley. 2002. Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent. J. Bacteriol. 184:2100-2107.
23. Parker, C. T. 2004. Diversity in the lipooligosaccharide biosynthesis locus of Campylobacter jejuni. NCBI accession number AY434498. Produce Safety and Microbiology Unit, United States Department of Agriculture, Agriculture Research Service, Albany, Calif.
24. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V. Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. Rajandream, K. M. Rutherford, A. H. van Vliet, S. Whitehead, and B. G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
25. Pearson, B. M., C. Pin, J. Wright, K. I'Anson, T. Humphrey, and J. M. Wells. 2003. Comparative genome analysis of Campylobacter jejuni using whole genome DNA microarrays. FEES Lett. 554:224-230.
26. Penner, J. L., and J. N. Hennessy. 1980. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J. Clin. Microbiol. 12:732-737.
27. Penner, J. L., J. N. Hennessy, and R. V. Congi. 1983. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur. J. Clin. Microbiol. 2:378-383.
28. 1 ganglioside. Infect. Immun. 66:3649-3655.
29. van Koningsveld, R., R. Rico, I. Gerstenbluth, P. I. Schmitz, C. W. Ang, I. S. Merkies, B. C. Jacobs, Y. Halabi, H. P. Endtz, F. G. van der Meche, and P. A. van Doorn. 2001. Gastroenteritis-associated Guillain-Barre syndrome on the Caribbean island Curacao. Neurology 56:1467-1472.
30. Willison, H. J., and G. M. O'Hanlon. 1999. The immunopathogenesis of Miller Fisher syndrome. J. Neuroimmunol. 100:3-12.